Lowering the glycemic index (GI) or carbohydrate content of mixed meals reduces blood glucose and insulin levels throughout the day without influencing satiety….
Read More »Yearly Archives: 2012
Cholecalciferol Preserves Beta-Cell Function in Type 1 Patients
In a small randomized trial, cholecalciferol helped preserve beta-cell function in patients with new-onset type 1 diabetes….
Read More »Start Insulin at Lower Dose for Diabetes Patients with Renal Insufficiency
Hospitalized patients with type 2 diabetes and renal insufficiency might benefit from lower than standard weight-based initial doses of insulin glargine or glulisine….
Read More »Editor’s Desk: New Homerun Slides on eAG
Two years ago there was a great deal of press about the use of the Estimated Average Glucose (eAG) and how this would revolutionize diabetes care, making things easier for our patients to understand their diabetes. However in practice there has not been a big shift in that direction. Now …
Read More »Exercise and Sport in Diabetes, 2nd Ed: Guidelines for Carbohydrate Intake Before Exercise
Diet and Nutritional Strategies During Sport and Exercise in Type 1 Diabetes Elaine Hibbert-Jones and Gill Regan What should the target level of blood glucose be before exercise?
Read More »Use of the Estimated Average Glucose (eAG) in Patient Care, Part 1 of 2
In this week’s Homerun Slides, we examine the use of eAG which is not always just confusing to patients.
Read More »ORIGIN Trial and Steve Freed Question, AACE 2012
Silva A. Arslanian, MD: Difficulties of Educating Parents
Silva A. Arslanian, MD, talks about the particular challenges of type 2 diabetes in adolescence and the role parents should but often do not play in helping to manage their children’s diabetes….
Read More »Silva A. Arslanian, MD, Q4: Disparities in diabetes rates between children of different socio-economic class
Dr. Arslanian confirms that she is seeing a higher incidence of type 2 diabetes in children in lower socio-economic classes, where there is also a higher obesity rate. More videos with Dr. Arslanian: Silva A. Arslanian, MD, Introduction T2DM in Children – Earlier co-morbidities? What drugs can be prescribed to …
Read More »Silva A. Arslanian, MD: How does the drug approval process differ for children?
Silva A. Arslanian, MD, explains the rigorous process for gaining approval for new diabetes drugs for children, and points out that the type 2 rate is not yet at epidemic proportions in children (as it is in adults)….
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.